+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Dermatological Drugs Market Research Reports

Acne Vulgaris- Pipeline Insight, 2024 - Product Thumbnail Image

Acne Vulgaris- Pipeline Insight, 2024

  • Clinical Trials
  • August 2024
  • 80 Pages
  • Global
From
Lichen Planus- Pipeline Insight, 2024 - Product Thumbnail Image

Lichen Planus- Pipeline Insight, 2024

  • Clinical Trials
  • August 2024
  • 60 Pages
  • Global
From
Scleroderma - Pipeline Insight, 2024 - Product Thumbnail Image

Scleroderma - Pipeline Insight, 2024

  • Clinical Trials
  • August 2024
  • 240 Pages
  • Global
From
Urticaria - Pipeline Insight, 2024 - Product Thumbnail Image

Urticaria - Pipeline Insight, 2024

  • Drug Pipelines
  • July 2024
  • 80 Pages
  • Global
From
Vitiligo - Pipeline Insight, 2024 - Product Thumbnail Image

Vitiligo - Pipeline Insight, 2024

  • Clinical Trials
  • July 2024
  • 80 Pages
  • Global
From
From
From
From
From
From
From
From
From
From
From
From
From
From
From
From
Loading Indicator

The Dermatological Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs used to treat skin conditions. These drugs are used to treat a variety of skin conditions, including acne, eczema, psoriasis, and skin cancer. Dermatological drugs are typically administered topically, although some may be taken orally. The Dermatological Drugs market is highly competitive, with many companies vying for market share. Major players in the market include Johnson & Johnson, GlaxoSmithKline, Pfizer, Merck, and Novartis. These companies are engaged in research and development of new drugs, as well as marketing and distribution of existing products. Additionally, many smaller companies are involved in the production of generic dermatological drugs. Show Less Read more